Catalyst Wire Dossier Catalyst Wire Dossier

CD07223 Gel

· Galderma R&D
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD07223 Gel, covering 2021-02-18 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne [Phase 2]

See pricing